Clinical trial
Methylnaltrexone for the Reversal of Opiate-Induced Constipation in the Intensive Care Unit
NCT01050595 is registered in ClinicalTrials.gov with St. John Health System, Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Methylnaltrexone for the Reversal of Opiate-Induced Constipation in the Intensive Care Unit
- Lead sponsor
- St. John Health System, Michigan
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2009
- Completion date
- December 31, 2010
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.